Skip to main content
DOSAGE AND ADMINISTRATION

YOU DECIDE: PATIENTS SELF-ADMINISTER
AT
HOME OR YOU ADMINISTER IN
THE OFFICE1

YOU DECIDE: PATIENTS SELF-ADMINISTER
AT
HOME OR YOU ADMINISTER IN
THE OFFICE1

DOSING FOR PATIENTS WITH AFRS1


Adult
(aged 18+ years)

300mg
Recommended Dosage

Every2 Weeks

1 pre-filled pen or syringea

Pediatric
(aged 6-17 years)

Body Weight
15 to <30 kgb
300mg
Recommended Dosage

Every4 Weeks

1 pre-filled pen or syringea

Body Weight
30 to <60 kgb
200mg
Recommended Dosage

Every2 Weeks

1 pre-filled pen or syringea

Body Weight
≥60 kgb
300mg
Recommended Dosage

Every2 Weeks

1 pre-filled pen or syringea

a300 mg=2 mL solution; 200 mg=1.14 mL solution.
b15 kg is equal to 33 lb, 30 kg is equal to 66 lb, and 60 kg is equal to 132 lb.

Consider Before Injecting1

DUPIXENT is administered by subcutaneous injection and is intended for use under the guidance of a healthcare provider.

  • Provide proper training to patients and/or caregivers on the preparation and administration of DUPIXENT prior to use, according to the Instructions for Use
  • Rotate injection site with each injection
  • A caregiver or patient may inject DUPIXENT after training in subcutaneous injection technique using the pre-filled syringe or pre-filled pen
  • Consider completing all age-appropriate vaccinations as recommended by current immunization guidelines prior to initiating treatment with DUPIXENT

Two Administration Options for You and Your Patients1-5

Important Administration Instructions1

  • Patients and/or caregivers should read the Instructions for Use prior to injecting
  • Instruct patients and/or caregivers to administer the subcutaneous injection
    into the thigh or abdomen, except for the 2 inches (5 cm) around the navel
  • The upper arm can also be used if a caregiver administers the injection
  • It is important to rotate the injection site with each injection. DO NOT inject
    DUPIXENT into skin that is tender, damaged, bruised, or scarred

See the Instructions for Use for more detailed instructions on the preparation and administration of DUPIXENT.

For additional administration information, see Prescribing Information here.

Missed dose information1

If an every-2-week dose is missed, administer the injection within 7 days from the missed dose and then resume the patient’s original schedule. If the missed dose is not administered within 7 days, administer the dose, starting a new schedule based on this date.

If an every-4-week dose is missed, administer the injection within 7 days from the missed dose and then resume the patient’s original schedule. If the missed dose is not administered within 7 days, administer the dose, starting a new schedule based on this date.

Before injection, instruct patients and/or caregivers to remove DUPIXENT from the refrigerator and allow DUPIXENT to reach room temperature without removing the needle cap.

  • 45 minutes for the 300 mg/2 mL pre‑filled syringe or pre-filled pen
  • 30 minutes for the 200 mg/1.14 mL pre-filled syringe or pre-filled pen

Patients and/or caregivers should inspect DUPIXENT visually for particulate matter and discoloration prior to administration.

  • Do not use if the liquid contains visible particulate matter or is discolored or cloudy (other than clear to slightly opalescent, colorless to pale yellow)

Patients and/or caregivers should discard any unused product remaining in the pre‑filled syringe or pre-filled pen in accordance with local requirements.

Check Formulary Status in Your Area

See insurance coverage status, prior authorization, and step edit information for DUPIXENT.